Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001189130-26-000005

Director acquired 6,408 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FLATLEY JAY T Director 2026-06-03 Grant or award +6,408 22,628 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
FLATLEY JAY T Director 2026-06-03 Grant or award · Stock Option (right to buy) +19,226 19,226 D: show line 2 in the form
Loading xslF345X06/wk-form4_1780692384.xml…